Tuesday, May 6, 2008

[StemCells] Marrow SCs may help Parkinson's (up to 80%)

Stem Cell Implant to the Brain Helps Improve Parkinson's Symptoms:
Presented at SIR
By Ed Susman

WASHINGTON, DC -- March 24, 2008 -- All of the patients with
Parkinson's disease who were treated by implantation of stem cells
into the brain have achieved substantial improvement in terms of
beneficial changes that were apparent within 1 week of the implant
procedure.

"Our 1 patient who has reached 1 year following the implant has
achieved an 80% improvement in his Parkinson's disease-related
symptoms," said Augusto Brazzini Armestar, MD, Director, Instituto
Brazzini Radiologos Asociados, Lima, Peru.

In his featured poster presentation on March 18 here at the Society
of Interventional Radiology (SIR) 33rd Annual Scientific Meeting, Dr.
Armestar said the implants of purified autologous bone-marrow-derived
stem cells were attempted in hopes that the cells would implant in
areas of the brain depleted of neurotransmitters.

"Stem cells from bone marrow have the ability to differentiate into
neurons and other tissues," he said. "Usually stem cells migrate to
sites of injury. However, they do so in very small quantities, and so
full regeneration is not gained."

Dr. Armestar and his colleagues attempted to get more of the stem
cells into the brain by using interventional radiological techniques.
Stem cells were first harvested from patients' bones and were sent to
the pathology laboratory to be separated and purified, at which time
they were returned to the operating theatre.

A team of interventionists advanced a catheter from an incision into
the groin that gained access to the arterial system. From there,
under imaging guidance, the catheter was advanced through the carotid
artery, the posterior cerebral arteries, and the posterior
communicating arteries. At that time, the stem cells were slowly
infused through the catheter into the arteries that irrigate the
basal nucleus and the substantia nigra -- an area where neurons are
depleted in Parkinson's patients.

To date, Dr. Armestar's team has implanted stem cells in 15 women and
32 men. The average age of the patients was about 50 years;
Parkinson's disease had been diagnosed from 1 year to 18 years before
implantation.

At the 1-week follow-up, 39 patients had achieved a 35% improvement
as assessed by a battery of Parkinson's disease validated tests. At
the 1-month follow-up, 34 patients showed a 52% improvement. At 3
months, 23 patients had improved an average of 59%; at 6 months, 6
patients had improved 76%; after 12 months the 1 person to reach that
level had achieved an 80% improvement (P < .001), he said.

"Our findings show a clinical recovery of extrapyramidal symptoms,
which are maintained over time, as well as function recovery,
representing a better metabolism of neurons and better performance in
the brain," Dr. Armestar said.

[Presentation title: Intra Arterial Autologous Implant of Adult Stem
Cell for Patients With Parkinson's Disease. Abstract 301]

http://www.docguide.com/news/content.nsf/news/852571020057CCF685257416
00511A24

__._,_.___
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:

Children's Neurobiological Solutions
http://www.CNSfoundation.org/

Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123

The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
Yahoo! News

Odd News

You won't believe

it, but it's true

Yahoo! Finance

It's Now Personal

Guides, news,

advice & more.

All-Bran

10 Day Challenge

Join the club and

feel the benefits.

.

__,_._,___

No comments:



about stem cell research
adult stem cell
adult stem cell research
adult stem cells
against stem cell
against stem cell research
anti stem cell
anti stem cell research
autologous stem cell
autologous stem cell transplant
benefits of stem cell research
blood stem cells
bone marrow stem cells
bush stem cell
california stem cell
cancer stem cell
cancer stem cells
cell stem cell
cons of stem cell research
cord blood stem cell
cord blood stem cells
cord stem cells
diabetes stem cell
embryonic stem cell
embryonic stem cell research
embryonic stem cells
for stem cell research
funding for stem cell research
harvard stem cell
harvard stem cell institute
hematopoietic stem cell
hematopoietic stem cells
history of stem cell research
human embryonic stem cell
human embryonic stem cell research
human embryonic stem cells
international stem cell
mesenchymal stem cell
mesenchymal stem cells
neural stem cell
neural stem cells
nih stem cell
pluripotent stem cells
pro stem cell
pro stem cell research
pros and cons of stem cell
pros and cons of stem cell research
stem cell
stem cell bank
stem cell bill
stem cell biology
stem cell companies
stem cell conference
stem cell controversy
stem cell cures
stem cell debate
stem cell differentiation
stem cell ethics
stem cell funding
stem cell heart
stem cell information
stem cell institute
stem cell line
stem cell lines
stem cell news
stem cell policy
stem cell reasearch
stem cell reaserch
stem cell reseach
stem cell research
stem cell research articles
stem cell research bill
stem cell research controversy
stem cell research debate
stem cell research enhancement act
stem cell research ethics
stem cell research facts
stem cell research funding
stem cell research pros
stem cell research pros and cons
stem cell reserach
stem cell reserch
stem cell technologies
stem cell technology
stem cell therapy
stem cell transplant
stem cell transplantation
stem cell transplants
stem cell treatment
stem cell treatments
stem cell veto
stem cells
stem cells research
support stem cell research
types of stem cells
umbilical cord stem cells
what are stem cells
what is a stem cell
what is stem cell
what is stem cell research